Newly identified pancreatogenic diabetes or type 3c diabetes (T3cD) getting wrongly diagnosed with type 2 diabetes (T2D)
Researchers have identified new type 3c diabetes (also known as pancreatogenic diabetes T3cD). Damage to the pancreas due to tumors, inflammation or surgery causes the development of type 3c diabetes. This type of diabetes weakens the insulin production from beta cells (to control blood glucose levels or glycemic control) and also weakens the production of digestive enzymes (proteins) and other hormones (for the digestion of the food). Diabetes may not be developed in all people with pancreas diseases, damage or injury. Diabetes development may take more than 10 years in most of the people with pancreatic diseases, damage or injury.
Medical professionals are wrongly diagnosing most of the type 3c diabetes conditions as type 2 diabetes (T2D) conditions. Diagnosis of type 3c diabetes is being overlooked due to the long delay in the development of type 3c diabetes and medical professionals failed to link pancreas diseases, damage or injury to the pancreatogenic diabetes or type 3c diabetes (T3cD) disease developing.
A large-scale study was conducted among 2 million patients, all age groups, in England. Researchers used the Royal College of General Practitioners Research and Surveillance Database (RCGP RSC) to find out the prevalence of type 3c diabetes. The study also focused on finding how type 3c diabetes patients are controlling their blood sugar levels.
Researchers looked into those patient records who were diagnosed with diabetes after receiving damage to pancreas with events such as hemochromatosis, cystic fibrosis, pancreatic cancer and tumors, pancreatitis and pancreatic surgery, which may increase the risk of the development of type 3c diabetes or pancreatogenic diabetes (T3cD). The study finding among newly diagnosed adult diabetes patients are
These results increase concerns that the type 3c diabetes is more common and this type of diabetes is not being diagnosed properly. The wrong diagnosis of type diabetes is a waste of time, money and a risk of high blood sugar or glucose levels. Type 2 diabetes (T2D) treatment and drugs such as gliclazide are not effective in the treatment of type 3c diabetes. Small study results show type 3c diabetes patients will be benefited by taking insulin injection and also digestive enzymes (in a tablet, liquid or pill form) along with the food. Some tips to prevent the development of type 3c diabetes or pancreatogenic diabetes (T3cD) are
Pancreatitis : Pancreas organ produces glucagon and insulin hormones and releases them into the bloodstream to control blood sugar levels. The organ also produces digestive enzymes and releases them into the small intestine for the digestion of the food. Sometimes, these digestive enzymes were activated before being released into the small intestine. These enzymes start attacking pancreas organ itself causing inflammation of the pancreas. This inflammation causes pancreatitis disease. Symptoms of pancreatitis disease are
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. Published article is not a medical advice by the OWNER of "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.